This high binding affinity to MCL-1 translated to cellular efficacy (Table 1), where cell death at subnanomolar concentrations was observed in tumor cell lines derived from MM (AMO-1, H929) and AML (MV4-11). The gene discussed is MCL1; the disease is Miyoshi myopathy.